Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
While neurocognitive impairments in attention, memory and executive functioning are commonly
reported sequelae of childhood leukemia and brain tumors, studies have only recently begun to
examine the treatment of attention deficits in this population. Numerous studies have
examined the effectiveness of methylphenidate in the treatment of children with attention
deficit hyperactivity disorder (ADHD). However, the effectiveness of this medication for
improving attention and behavioral functioning in children with medical illnesses or brain
injury are less clear.
Patients will be randomized to receive one week of Metadate CD (a controlled release form of
methylphenidate, similar to Ritalin) and one week of placebo in a double-blind fashion.
Phase:
N/A
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute